Reproductive health
Rosalind Ramsey-Goldman, MD,DrPH
Northwestern University
Chicago, Illinois, United States
Disclosure(s): Ampel Solutions: Consultant (Ongoing); biogen: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Calabetta: Consultant (Ongoing); Exagen: Consultant (Ongoing); Immunocor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck/MSD: Consultant (Terminated, January 1, 2024)
Rashmi Dhital, MD
Vanderbilt University Medical Center
Brentwood, TN, United States
Disclosure information not submitted.
Menopause transition may present special challenges and questions for patients with rheumatic and musculoskeletal diseases (RMDs) and their treating rheumatologists. This session will focus on hormonal changes and common symptoms associated with menopause, along with their impact on underlying disease, as well as focus on hormonal and non-hormonal treatment aspects and address the safety consideration of hormone replacement therapy on different subpopulations of women with RMDs.
Speaker: Sharon Parish, MD – Weill Cornell Medical College
Speaker: Lisa Sammaritano, MD – Hospital for Special Surgery